Welcome to EFIM

Latest News

FDIME Announces the 15th Clinical Research Course

Seminar dates: 17 – 19 June 2019, Paris

See more



Stronger together for a healthier Europe

As we head towards the European Parliament elections in 2019, healthcare systems and citizens across Europe are facing unprecedented challenges driven by an ageing population, and increased prevalence of chronic diseases.
Research shows that 550,000 people of working age die from Non-Communicable Diseases in the EU every year. Aside from the significant impact on individual patients, their families and carers, this causes a largely avoidable loss to the EU economy of €115 billion per year, corresponding to 0.8% of GDP[1].

See more



Great news for the European internal medicine community!

Download the European Curriculum here
The European Board of Internal Medicine is considering strategies aimed at implementing the new curriculum across Europe, in collaboration with EFIM and the national internal medicine societies.

See more



1st European Advanced School of Internal Medicine in Riga

One of the greatest achievements in 2018 inspired by EFIM Young Internists was launching of the 1st European Advanced School of Internal Medicine (EASIM) in Riga, Latvia, directed by Dr. Ieva Ruža, on 24-26 November 2018. It was a small-scale international course by EFIM tailored to fill the gap in Internal Medicine postgraduate training for Early in Career internists in Europe. The EASIM design was based on the well-proven format of ESIM course for residents.

See more



EFIM General Assembly - 30 August, Wiesbaden, Germany

We would like to thank all the members of the EFIM national societies who joined us in Wiesbaden. This year’s General Assembly was held on 30 August at the RheinMain Congress Centre in Wiesbaden, in conjunction with the 17th European Congress of Internal Medicine.

See more



Pages

Coronavirus disease 2019 (COVID-19) – Short Notice for Public

Coronaviruses are important human and animal pathogens. Common human coronaviruses are responsible for approximately one-third of mild to moderate community-acquired upper respiratory tract infections in adults, like the common cold. This information should not be confused with Coronavirus disease 2019 (COVID-19). COVID-19 is the third coronavirus outbreak following the SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome) outbreaks in the 21st century. COVID-19 is a type of illness that can mainly affect the respiratory system.  Patients with COVID-19 usually complain of fever, cough and feeling tired. When the infection affects the lungs and causes pneumonia, shortness of breath is also observed. In some patients, COVID-19 can lead to respiratory failure, or even death. Read full notice here.
Further information: